DAVID
NAVARRO ORTEGA
CATEDRÁTICO/A DE UNIVERSIDAD
![Foto de DAVID](/img/nophoto.png)
![Foto de Hospital Universitario La Paz](/img/noimage_org.png)
Hospital Universitario La Paz
Madrid, EspañaPublicacions en col·laboració amb investigadors/es de Hospital Universitario La Paz (25)
2023
-
Mortality reduction in older COVID-19-patients hospitalized in Spain during the second pandemic wave from the SEMI-COVID-19 Registry
Scientific Reports, Vol. 13, Núm. 1
-
The role of the T-cell mediated immune response to Cytomegalovirus infection in intrauterine transmission
PLoS ONE, Vol. 18, Núm. 2 February
2022
-
Justification for 24/7 clinical microbiology services
Enfermedades Infecciosas y Microbiologia Clinica
2021
-
Spread of a SARS-CoV-2 variant through Europe in the summer of 2020
Nature, Vol. 595, Núm. 7869, pp. 707-712
-
The first wave of the COVID-19 epidemic in Spain was associated with early introductions and fast spread of a dominating genetic variant
Nature Genetics, Vol. 53, Núm. 10, pp. 1405-1414
2019
-
Clinical presentation of individuals with human T-cell leukemia virus type-1 infection in Spain
Open Forum Infectious Diseases, Vol. 6, Núm. 2
2017
-
Evaluation of the possible influence of trailing and paradoxical effects on the clinical outcome of patients with candidemia
Clinical Microbiology and Infection, Vol. 23, Núm. 1, pp. 49.e1-49.e8
-
HIV type 2 epidemic in Spain: Challenges and missing opportunities
AIDS, Vol. 31, Núm. 10, pp. 1353-1364
-
Human T-lymphotropic virus type 1 infection and disease in Spain
AIDS, Vol. 31, Núm. 12, pp. 1653-1663
-
Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance
Clinical Microbiology and Infection, Vol. 23, Núm. 9, pp. 672.e1-672.e11
-
Prevalence and distribution of hepatitis C virus genotypes in Spain during the 2000-2015 period (the GEHEP 005 study)
Journal of Viral Hepatitis, Vol. 24, Núm. 9, pp. 725-732
-
Rate and predictors of treatment failure to all-oral HCV regimens outside clinical trials
Antiviral Therapy, Vol. 22, Núm. 4, pp. 307-312
2016
-
Empirical and targeted therapy of candidemia with fluconazole versus echinocandins: a propensity score–derived analysis of a population-based, multicentre prospective cohort
Clinical Microbiology and Infection, Vol. 22, Núm. 8, pp. 733.e1-733.e8
2015
-
A simple prediction score for estimating the risk of candidaemia caused by fluconazole non-susceptible strains
Clinical Microbiology and Infection, Vol. 21, Núm. 7, pp. 684.e1-684.e9
-
Association between individual and combined SNPs in genes related to innate immunity and incidence of CMV infection in seropositive kidney transplant Recipients
American Journal of Transplantation, Vol. 15, Núm. 5, pp. 1323-1335
-
Candida tropicalis bloodstream infection: Incidence, risk factors and outcome in a population-based surveillance
Journal of Infection, Vol. 71, Núm. 3, pp. 385-394
-
Epidemiology and outcome of candidaemia in patients with oncological and haematological malignancies: RESULTS from a population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 21, Núm. 5, pp. 491.e1-491.e10
2014
-
Epidemiology and predictive factors for early and late mortality in Candida bloodstream infections: A population-based surveillance in Spain
Clinical Microbiology and Infection, Vol. 20, Núm. 4
-
HIV-2 and HTLV-1 infections in Spain, a non-endemic region
AIDS Reviews, Vol. 16, Núm. 3, pp. 152-159
2012
-
Comparison of three statistical methods for establishing tentative wild-type population and epidemiological cutoff values for echinocandins, amphotericin B, flucytosine, and six Candida species as determined by the colorimetric sensititre yeastone method
Journal of Clinical Microbiology, Vol. 50, Núm. 12, pp. 3921-3926